Vertebral Compression Fractures (VCF) Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Vertebral Compression Fractures (VCF) Treatment Devices Market By Product Type (Vertebroplasty Devices And Kyphoplasty Devices), Surgery Type (Open Spine Surgery And Minimally Invasive Spine Surgery), End-User (Hospitals, Ambulatory Surgical Centers, and others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of osteoporosis and growing postmenopausal women population

The global vertebral compression fractures (VCF) treatment devices market is estimated to grow at a CAGR of 7.5% during the forecast period from 2024 to 2030. The demand for vertebral compression fracture (VCF) treatment devices is primarily being boosted by the increasing patient population suffering from osteoporosis which is responsible for causing vertebral compression fracture (VCF), the surge in number of associated risk factors such as old age, obesity, and others, the growing population of postmenopausal women, and innovation in product development among others, thereby contributing to the overall growth of the vertebral compression fractures (VCF) treatment devices market during the forecast period from 2024-2030.

Vertebral Compression Fractures (VCF) Treatment Devices Market Dynamics:

According to the World Health Organization (WHO) 2022, musculoskeletal conditions are the leading contributor to disability, and worldwide around 1.71 billion people are suffering from musculoskeletal diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, and others.

As per the International Osteoporosis Foundation 2021, there were around 3,775,000 individuals with osteoporosis in the United Kingdom in 2019.

The 2023 data based on self-reported data from the Australian Bureau of Statistics (ABS) 2017-18 National Health Survey (NHS) presented by the Australian Institute of Health and Welfare stated that an estimated 924,000 Australians have osteoporosis. As per the same source, there were 9,300 hospitalizations with a principal diagnosis of osteoporosis for people aged 45 and over in 2020-21 in Australia.

Because osteoporosis disturbs bone microarchitecture and changes the content of noncollagenous proteins in the bone matrix, bone mineral density is reduced. This tissue structure degradation results in weak bones that are prone to fractures.

The increasing geriatric population prone to various orthopedic disorders including osteoporosis which is the most common etiology of vertebral compression fractures (VCF), and others is further accelerating the demand for vertebral compression fractures (VCF) treatment devices. According to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The elderly population aged 60 and above is expected to double in number representing about 2.1 billion people by 2050. Also, people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million.

The growing postmenopausal women population at risk of osteoporotic bone due to hormonal changes is further going to assist in the market growth. As per WHO 2022, in 2021, women aged 50 and over accounted for 26% of all women and girls globally. This was up from 22% 10 years earlier. The menopausal transition most often begins between ages 45 and 55.

However, the occurrence of post-surgical complications, the stringent regulatory approval for the devices, and reimbursement issues may restrict the growth of the overall vertebral compression fractures (VCF) treatment devices market.

Vertebral Compression Fractures (VCF) Treatment Devices Market Segment Analysis:

Vertebral Compression Fractures (VCF) Treatment Devices Market by Product Type (Vertebroplasty Devices and Kyphoplasty Devices), Surgery Type (Open Spine Surgery and Minimally Invasive Spine Surgery), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the vertebral compression fractures (VCF) treatment devices market, the kyphoplasty devices category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with kyphoplasty devices for the effective treatment of vertebral compression fractures (VCF).

Kyphoplasty devices are found to restore vertebral body height and rectify vertebral body deformities. Individuals report a significant and lasting reduction in back discomfort.

Other advantages of kyphoplasty devices include sustained vertebral body height restoration, significant and sustained improvement in quality of life, significant and sustained improvement in mobility, and others.

It reduces the number of days per month when pain interferes with daily activities and improves the overall ability of a person to perform activities walking, hobbies, and work.

A significant reduction in the number of days per month that a patient remains in bed due to back pain is observed after surgery via kyphoplasty devices.

During the surgical procedure, orthopedic balloons are used to restore spinal height and cure angular deformity caused by VCF resulting from osteoporosis, malignancy, or benign lesions. The balloons are deflated and removed after reduction. The cavity formed as a result enables the controlled deposition of bone cement to produce an internal cast and stabilize the fracture.

Therefore, owing to the above-mentioned factors, the kyphoplasty devices category is expected to register significant growth, thereby driving the growth of the overall vertebral compression fractures (VCF) treatment devices market during the forecast period.

North America is expected to dominate the overall Vertebral Compression Fractures (VCF) Treatment Devices Market:

Among all the regions, North America is estimated to account for the largest share of the vertebral compression fractures (VCF) treatment devices market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of various orthopedic disorders, rise in old age population, surge in cases of injuries and fractures due to sudden accidents, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for vertebral compression fractures (VCF) treatment devices is expected to witness prosperity in the region during the forecast period 2024-2030.

Osteoporosis, a disease characterized by weaker bones that tend to break is highly prevalent across the United States. As per the latest data published by the Office of Disease Prevention and Health Promotion, 1 in 10 people aged 50 years have osteoporosis in the United States. The Bone Health & Osteoporosis Foundation's latest data also mentioned about 10 million people in the US having osteoporosis and another 44 million with low bone density, placing them at increased risk. As per the same source, 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone and should be concerned about bone health.

The increasing age makes one susceptible to several health issues including bone diseases, and others, and thus is another driver for the growth of the vertebral compression fractures (VCF) treatment devices market. According to CDC 2022, around 54.1 million US adults were aged 65 or older in 2019. As per the same source, it has been estimated that by 2060, this number will reach up to 94.7 million in the US.

As per the Administration of Community Living 2021, the population aged 65 and above was 54.1 million, and out of that 30 million were women. Older women are more at risk of suffering from osteoporosis and in turn vertebral compression fractures (VCF).

Thus, the above-mentioned factors are likely to propel the growth of the vertebral compression fractures (VCF) devices market in the region during the forecast period from 2024-2030.

Vertebral Compression Fractures (VCF) Treatment Devices Market Key Players:

Some of the key market players operating in the vertebral compression fractures (VCF) treatment devices market include Medtronic, Stryker, Globus Medical, IZI Medical, Amber Implants, Safe Orthopaedics, and others.

Recent Developmental Activities in the Vertebral Compression Fractures (VCF) Treatment Devices Market:

IZI Medical Products, LLC ("IZI"), a leading manufacturer of interventional radiology devices and products to treat vertebral compression fractures, launched Vertefix HV Cement ("Vertefix HV"), a unique solution that addresses the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty procedures.

In August 2020, IZI Medical Products, LLC announced the official launch of its Osteo-Site Vertebral Balloon ("Osteo-Site Balloon") for vertebral augmentation.

Key Takeaways from the Vertebral Compression Fractures (VCF) Treatment Devices Market Report Study

Market size analysis for current vertebral compression fractures (VCF) treatment devices market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global vertebral compression fractures (VCF) treatment devices market.

Various opportunities are available for the other competitors in the vertebral compression fractures (VCF) treatment devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current vertebral compression fractures (VCF) treatment devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vertebral compression fractures (VCF) treatment devices market growth in the coming future?

Target Audience who can be benefited from this Vertebral Compression Fractures (VCF) Treatment Devices Market Report Study

Vertebral Compression fracture (VCF) Treatment Devices product providers

Research organizations and consulting companies

Vertebral Compression Fractures (VCF) Treatment Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in vertebral compression fractures (VCF) treatment devices

Various End-users who want to know more about the vertebral compression fractures (VCF) treatment devices market and the latest technological developments in the vertebral compression fractures (VCF) treatment devices market.

Frequently Asked Questions for the Vertebral Compression Fractures (VCF) Treatment Devices Market:

1. What is meant by vertebral compression fracture (VCF) treatment devices?

Vertebral compression fractures (VCF) treatment devices are intended for the treatment of vertebral compression fractures (VCF) of the spine.

2. What is the market for global vertebral compression fractures (VCF) devices?

The global vertebral compression fractures (VCF) treatment devices market is estimated to grow at a CAGR of 7.5% during the forecast period from 2024 to 2030.

3. What are the drivers for the global vertebral compression fractures (VCF) devices market?

The demand for vertebral compression fractures (VCF) treatment devices is primarily being boosted by the increasing patient population suffering from various musculoskeletal disorders like osteoporosis and others, the surge in number of risk factors such as old age, obesity, and others associated with causing spinal problems, rising awareness regarding bone health, growing postmenopausal women population, and others, thereby contributing to the overall growth of the vertebral compression fractures (VCF) treatment devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global vertebral compression fractures (VCF) treatment devices market?

Some of the key market players operating in the vertebral compression fractures (VCF) treatment devices market include Medtronic, Stryker, Globus Medical, IZI Medical, Amber Implants, Safe Orthopaedics, and others.

5. Which region has the highest share in the vertebral compression fractures (VCF) treatment devices market?

North America is expected to dominate the overall vertebral compression fractures (VCF) treatment devices market during the forecast period from 2024-2030. Owing to factors such as the rising prevalence of osteoporosis, surge in the old age population, rise in cases of trauma and fractures, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness among others, North American vertebral compression fractures (VCF) devices market is expected to growth in coming years.